Khadija Saeed, Author at TechStock²

Nvidia Stock (NVDA) Rallies on AI Lab Deal and Export-Rule Win: Fresh News, Forecasts and 2025 Outlook

As of Friday, December 5, 2025, Nvidia Corporation (NASDAQ: NVDA) is trading around $183 per share, giving the AI-chip giant a market capitalization of roughly $4.5 trillion and leaving it firmly at the center of global markets, AI infrastructure spending,

5 December 2025

Artificial Intelligence·Financial Forecasts·Investment News·NVIDIA·Stock Market

Tesla Stock Today (December 5, 2025): Budget Model 3 Launch, FSD Backlash and Big 2030 Price Targets

Tesla, Inc. (NASDAQ: TSLA) is back above the $450 mark as investors digest a packed news day: a new low‑cost Model 3 for Europe, fresh data from China and Norway, a controversial Full Self‑Driving (FSD) software update, and wildly different

5 December 2025

Electric Vehicles·Investment Analysis·Stock Market·Tesla News

NYC F and M Subway Lines to Swap Queens–Manhattan Routes Monday: Delays, New Stops and How Your Commute Will Change

Beginning Monday, December 8, 2025, New York City’s F and M subway lines will undergo a major weekday shake‑up between Queens and Manhattan. On weekdays from about 6:00 a.m. to 9:30 p.m., the Metropolitan Transportation Authority (MTA) will permanently swap

5 December 2025

News

Cooper Companies (NASDAQ: COO) Soars on Strategic Review and Q4 Beat: Stock Forecast and Analysis After 4 December 2025

The Cooper Companies, Inc. (CooperCompanies, NASDAQ: COO) just dropped a packed news day: fiscal Q4 2025 earnings, upbeat 2026 guidance, a formal strategic review, and a change in board leadership. Together, these announcements on 4 December 2025 jolted COO stock

5 December 2025

Company Analysis·Earnings Reports·Financial News·Investment Strategies·Stock Market

TD Bank Q4 2025 Earnings: Dividend Hike, Deep Cost Cuts and AML Fallout Shape 2026 Outlook

Toronto-Dominion Bank (TD Bank Group, TSX: TD; NYSE: TD) ended 2025 with a paradox that’s becoming familiar to big-bank investors: lower reported profit, stronger underlying performance – and a higher dividend. On December 4, 2025, the bank reported fourth‑quarter results

5 December 2025

Banking·Dividends·Earnings Reports·Financial Outlook

Praxis Precision Medicines (PRAX) Stock Surges on FDA Progress and Epilepsy Trial Wins: Latest News and 2026 Forecast

Updated December 5, 2025 – all developments since December 4, 2025 Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has moved back into the market spotlight after a flurry of major announcements on December 4, 2025. The biotech’s stock — already one

5 December 2025

Biotech News·FDA Updates·Investment Forecasts·Stock Market

Picard Medical (PMI) Stock Soars 82% After Artificial Heart Breakthrough: Is This Rally Sustainable?

Picard Medical, Inc. (NYSE American: PMI) just staged one of the most dramatic moves on Wall Street, with its stock surging more than 80% on December 4, 2025, after the company released new data on its next‑generation artificial heart. Investors

5 December 2025

Biotechnology·Healthcare Innovation·Investment Analysis·Medical Technology·Stock Market

ChargePoint (CHPT) Stock Surges After Q3 FY 2026 Earnings Beat and $172 Million Debt Cut – Is a Turnaround Under Way?

ChargePoint Holdings, Inc. (NYSE: CHPT) is back in the spotlight after reporting third quarter fiscal 2026 results (quarter ended October 31, 2025) and unveiling a major balance sheet overhaul. The EV‑charging network operator delivered a return to revenue growth, record

5 December 2025

Earnings Reports·Electric Vehicles·Financial News·Investment Analysis·Stock Market

Argan (AGX) Stock: Q3 2026 Earnings Beat, Record $3 Billion Backlog and What December 4, 2025 Means for the Forecast

Published: December 4–5, 2025 | Ticker: NYSE: AGX Argan, Inc. (AGX) just delivered another strong quarter – and the market promptly punished the stock after hours. On December 4, 2025, the engineering and construction group reported fiscal Q3 2026 results

5 December 2025

Earnings Reports·Financial Updates·Investment News·Market Forecasts·Stock Analysis

KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update

KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the most volatile biotech penny stocks on the market in late 2025. After a failed eye‑disease trial, a loan default and a near‑miss with foreclosure, the company is now trying

5 December 2025

Biotech Stocks·Financial Analysis·Investment News·Nasdaq Updates·Stock Market

BigBear.ai (BBAI) Soars 15% on Defense‑AI Hype: Ask Sage Deal, New Forecasts and Key Risks as of December 4, 2025

BigBear.ai Holdings, Inc. (NYSE: BBAI) just delivered one of the most eye‑catching moves in the U.S. AI small‑cap space. On Thursday, December 4, 2025, BBAI shares jumped about 15% to around $7.02, trading between roughly $6.02 and $7.18 on massive

5 December 2025

Artificial Intelligence·Company Analysis·Defense Technology·Investment Risks·Stock Market News

Zack Polanski’s Wealth Tax Gamble: How the Green Party’s New Economics Are Rewiring UK Politics

Three months ago, Zack Polanski was a relatively obscure Green politician. Today he is at the centre of Britain’s fiercest argument about tax, debt and the future of the left – hailed by some as the hopeful face of a

5 December 2025

Economic Policy